MYGN FY 2020 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$487M

FY 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$557M-12.8% YoY

Gross Profit

$379M68.0% margin

Operating Income

-$195M-35.0% margin

Net Income

-$224M-40.2% margin

EPS (Diluted)

$-2.99

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$40M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$538M

Stockholders' Equity

$881M

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$557M	$639M	-12.8%
Gross Profit	$379M	$453M	-16.3%
Operating Income	-$195M	-$232M	+15.9%
Net Income	-$224M	-$200M	-12.1%